Literature DB >> 22113160

Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan.

Yuko Kunimi1, Yuko Hirata, Michiko Aihara, Yumiko Yamane, Zenro Ikezawa.   

Abstract

BACKGROUND: Stevens-Johnson syndrome (SJS) associated with Mycoplasma pneumoniae (M. pneumoniae) infection is mainly observed in children. In adults, drugs are a major cause of SJS, but some adult patients with SJS are infected with M. pneumoniae. We analyzed patients with SJS associated with M. pneumoniae infection to elucidate the differences between drug-induced SJS and M. pneumoniae-associated SJS and also to study differences between M. pneumoniae-associated SJS in children and adults.
METHODS: This is a retrospective review of Japanese patients who have been reported as M. pneumoniae-associated SJS in medical Journals published from 1981 to 2009, compared with data of Japanese patients with drug-induced SJS reported from 2000 to 2009.
RESULTS: Thirty-eight cases of M. pneumoniae-associated SJS and 78 cases of drug-induced SJS were analyzed in this study. Ocular lesions were observed more frequently in M. pneumoniae-associated SJS than in drug-induced SJS (p < 0.01), and adult patients showed a higher ratio of sequelae in their eyes than did patients under 20 years of age (p < 0.01). Sixty-six percent of adult patients with M. pneumoniae-associated SJS developed fever/respiratory symptoms and mucocutaneous lesions on the same day. In contrast, most of the patients under 20 years of age developed fever/respiratory symptoms before mucocutaneous involvement. This means that these adult patients were infected and immunized previously and developed allergic reactions to M. pneumoniae soon after the later infection.
CONCLUSIONS: In order to prevent ocular sequelae in adult patients when M. pneumoniae infection is suspected, more intensive treatment may be needed in adult patients than in younger patients.

Entities:  

Mesh:

Year:  2011        PMID: 22113160     DOI: 10.2332/allergolint.11-OA-0309

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  10 in total

1.  Rare extrapulmonary complications of Mycoplasma pneumoniae infection.

Authors:  Kiran Dhaliwal; Kevin Enright
Journal:  BMJ Case Rep       Date:  2016-02-01

2.  Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.

Authors:  Jacqueline F Moreau; Robert S Watson; Mary E Hartman; Walter T Linde-Zwirble; Laura K Ferris
Journal:  Pediatr Dermatol       Date:  2013-05-16       Impact factor: 1.588

3.  Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome.

Authors:  Daniel Olson; Louise K Francois Watkins; Alicia Demirjian; Xia Lin; Christine C Robinson; Kristin Pretty; Alvaro J Benitez; Jonas M Winchell; Maureen H Diaz; Lisa A Miller; Teresa A Foo; Melanie D Mason; Ursula L Lauper; Oren Kupfer; Jeffrey Kennedy; Mary P Glodé; Preeta K Kutty; Samuel R Dominguez
Journal:  Pediatrics       Date:  2015-08       Impact factor: 7.124

Review 4.  Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis.

Authors:  Mitsuo Narita
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

5.  Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Lucia Liotti; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Fabio Cardinale; Francesca Saretta; Francesca Mori; Giuseppe Crisafulli; Fabrizio Franceschini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-29

6.  Case Report and Literature Review: Clinical Characteristics of 10 Children With Mycoplasma pneumoniae-Induced Rash and Mucositis.

Authors:  Ning Chen; Miao Li
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

Review 7.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

8.  Mycoplasma pneumoniae-Induced-Stevens Johnson Syndrome: Rare Occurrence in an Adult Patient.

Authors:  Samad Rasul; Faria Farhat; Yared Endailalu; Fatima Tabassum Khan; Vishal Poddar
Journal:  Case Rep Med       Date:  2012-08-16

Review 9.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

10.  Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).

Authors:  Saskia Ingen-Housz-Oro; Tu-Anh Duong; Benoit Bensaid; Nathalia Bellon; Nicolas de Prost; Dévy Lu; Bénédicte Lebrun-Vignes; Julie Gueudry; Emilie Bequignon; Karim Zaghbib; Gérard Royer; Audrey Colin; Giao Do-Pham; Christine Bodemer; Nicolas Ortonne; Annick Barbaud; Laurence Fardet; Olivier Chosidow; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.